Dataset | samples | features | class 1(#samples) | class 2(#samples) |
---|---|---|---|---|
1 Wang et al. - Breast cancer [50] | 286 | 22.283 | ER+(209) | ER-(77) |
2 Verhaak et al. - Leukemia [51] | 461 | 54.675 | NPM1 pos.(140) | NPM1 neg.(321) |
3 Haferlach et al. - Leukemia [52] | 251 | 54.675 | NPM1 pos.(138) | NPM1 neg.(113) |
4 Haferlach et al. - Leukemia [52] | 77 | 54.675 | AML with t(8;21)(40) | AML with t(15;17)(37) |
5 Golub et al. - Leukemia [53] | 72 | 7.129 | ALL(47) | AML(25) |
6 Chiaretti et al. - Leukemia [54] | 22 | 12.625 | CLL stable(8) | CLL progressive(14) |
7 Alizadeh et al. - Lymphoma [55] | 38 | 18.432 | Activated B-like DLBCL(17) | GC B-like DLBCL(21) |
8 Nutt et al. - High-grade glioma [56] | 50 | 12.625 | Glioblastoma(28) | Anaplastic oligodendroglioma(22) |
9 Alon et al. - Colon cancer [57] | 62 | 2.000 | Tumor(42) | Normal(20) |
10 Singh et al. - Prostate cancer [58] | 102 | 12.600 | Tumor(52) | Normal(50) |